News | Image Guided Radiation Therapy (IGRT) | May 24, 2017

University Medical Centre Utrecht Treats First Cancer Patient With Elekta Unity MR-Guided Linear Acclerator

First of five planned patients in a clinical study has received therapy for spine metastases

May 24, 2017 — The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as part of a clinical study with the Elekta Unity magnetic resonance radiation therapy (MR/RT) system. Elekta Unity is capable of delivering precisely targeted radiation doses and capturing MR images of diagnostic quality. It is the first time a patient has been treated on a state-of-the-art linear accelerator with a high-field magnetic resonance imaging (MRI) system, according to Elekta.

The study, taking place at UMC Utrecht, aims to confirm the pre-clinically demonstrated technical accuracy and safety of Elekta Unity in the clinical setting. In the ongoing study, a total of five patients with spinal metastases will be treated with the system under a strict protocol, and will receive radiation treatment guided by MR imaging. Analysis of the first clinically derived data shows that visibility of the treatment target and radiation beam accuracy is excellent as expected.

Image-guided adaptive radiotherapy has become the standard of care to optimize the accuracy and precision of radiation delivery,” said Ina Jürgenliemk-Schulz, M.D., Ph.D., radiation oncologist at UMC Utrecht and principal investigator of the study. “Better visualization of the tumor targets and the surrounding healthy tissues at the exact moment of treatment, makes it possible to adapt the radiation dose to the actual tumor anatomy and optimally spare normal tissue during treatment. MR/RT with Elekta Unity will drive the paradigm shift from conventional highly fractionated treatments towards more ablative approaches, with smaller fields and fewer treatment fractions.”

UMC Utrecht is the founding member of Elekta’s MR-linac Consortium, a global collaboration of institutions bringing together leaders in radiation oncology, MR-imaging, physics and radiotherapists. The mission of the consortium is to investigate how MR-linac technology can lead to improved patient outcomes for existing radiation therapy indications and extend radiation therapy for additional indications.

Elekta Unity integrates a premium quality (1.5 Tesla) MR scanner, from MR technology partner Philips, with an advanced linear accelerator and intelligently designed software.

The system is a work in progress and not available for sale or distribution.

For more information: www.elekta.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...